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Diabetes mellitus is increasing world-wide in all countries, all ages and both genders”. This is a common 
sentence we have heard recent years which 
it could encourage people to read and search 
about the disease. It should be noted that 
most of the time, it may consider type 2 di-
abetes, however, is taht mean that type 1 di-
abetes is not important? Absolutely not. In 
fact, type 1 diabetes, a serious and life-threat-
ening disease with many complications, is 
one of the most common (autoimmune) en-
docrine and metabolic conditions in child-
hood, with life-saving treatment and lifelong, 
but painful and time-consuming in daily life, 
requiring self-action and a balanced diet, 
equally distributed among boys and girls (1). 
It is only 10%-15% of all types of diabetes (2). 
Two international collaborative programs; 
i.e., the Diabetes Mondiale study (DiaMond) 
and the Europe and Diabetes study (EURO-
DIAB) have been begun in the 1980s to mon-
itor the trends of incidence of disease (1). 
While some studies reported the decline in 
the mortality and morbidity from type 1 di-
abetes mellitus in Europe (3) and the United 
States (4)  in the past 30 years, some other 
studies reported worldwide increasing (5), 
with later onset of disease in Africa compared 
to western Europe (6-8), as well as Kuwait 
(9), Sudan (10), Egypt (11). Although, most 
of type 1 patients would be diagnosed in the 
first two decades of life, there is some evi-
dences that an increasing number of patients 
would be recognized in older ages (12,13), 
but not in Switzerland (14) with increase in 
under 5 year children incidence rates. 
Furthermore, there is a large variability of 
disease distribution around the world. Fin-
land with about 40/100 000 per year has 
the largest incidence rates of disease in the 
world compared to China with lowest inci-
dence rate of 0.1/100 000 per year (15). In the 
Middle East region, the incidence rate var-
ies from 1/100 000 to 8/100 000 per year in 
Pakistan and Egypt, respectively (16). Even 
within a country, there is variability across 
country (17) as well as urban-rural differ-
ence (18).
Nowadays, with increasing type 2 diabetes 
importance worldwide, due to unhealthy life 
style (as the main cause of disease) as well 
as the possibility of prevention or making a 
delay in onset and its complications, in ad-
dition to focus on finding a potential main 
preventive method to protect against type 
2 diabetes, one important question will be 
raised: “What is the future situation of type 1 
diabetes mellitus worldwide?”
In one hand, with development of new meth-
ods and increased awareness of populations, 
type 1 diabetes will be diagnosed faster and 
maybe new treatments can cure it more ef-
fective than now; one the other hand, in chil-
dren under 5 years old and older ages, it is 
going to show increase in incidence. What 
would be the difference between developed 
and developing countries? What will be the 
direct (treatment and medication) and in-
direct (social, productivity, stress on family 
members, and so on) costs of this disease 
compared to type 2 diabetes? How would be 
the future health policies for coping with this 
disease? 
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